Immunome, Inc.

Immunome, Inc.

Immunome, Inc.

Date Founded



3624 Market Street,Suite 5,Philadelphia, PA 19104

Type of Company


Employees (Worldwide)

11 - 50


Holding Companies

Company Description

Immunome, Inc. operates as a transformative immuno-oncology company. It creates new, safe, and powerful cancer therapies by targeting stem cell and universal cancer antigens. It offers discovery engine that enables the simultaneous discovery of novel tumor antigens and the cognate native human antibodies that target those antigens. The company was founded by Scott K. Dessain and Gregory P. Licholai in 2006 and is headquartered in Wynnewood, PA.

Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Treasurer

Head of Business Development

Media Contact

Board of Directors

Executive Chairman at Brand & Services Acquisition Corp.

Senior Investment Consultant at Pennsylvania Trust Co.

Founder at SiGNa Chemistry, Inc.

Member, Board of Directors at Immunome, Inc.

President & Chief Executive Officer at Immunome, Inc.

Secretary & Director at Plastron Acquisition Corp. IV

Paths to Immunome, Inc.
Potential Connections via
Relationship Science
Immunome, Inc.
Recent Transactions
Details Hidden

Immunome, Inc. raised money in a private placement transaction

Details Hidden

Immunome, Inc. raised money in a private placement transaction

Details Hidden

Immunome, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onImmunome, Inc. raised money in a private placement transaction

Details Hidden

BioAdvance invests in emerging life sciences companies loated in the mid-Atlantic region. The firm invest in therapeutics, medical devices, research tools, health IT,diagnostics and platform technologies focused on human health. Investments range from $250,000 to $500,000 and invests up to $1.5 million over the life of the investment. The firm also makes in pilot investments up to $50,000.

Details Hidden

Robin Hood Ventures focuses on investments in early-stage companies that have the potential for high return on investment. The firm target companies operating in the fields of technology, marketing, health services, internet services, communications, and finance sectors. Investments range from $0.25 to $1 Million for a single financing. The firm invests with co-investors and It makes board seat requirements also.

Details Hidden

Founder at Immunome, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Immunome, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Immunome, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Immunome, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15